Plant-based vaccines for emerging infectious diseases

Understanding the relationship of infectious materials with host immunity, along with the importance of faulty immune function in the progression of the disease, would be instrumental in explaining infectious pathogenicity, predisposing factors for the worst outcome, and the rational design of therapeutic interventions and immunization. There is a rising need for defended, improved, and effectual vaccine candidates against emerging infectious diseases in various components of the world. Plant-derived vaccines are primarily based on the protein components of infectious viruses. However, some vaccine candidates also use a unique pathogen target, such as the N protein. Tobacco plants have been used to create virus-like particles (VLPs), chimeric VLPs, protein subunit vaccines, and carrier molecule-fused protein subunit vaccines. The plant-based manufacturing process could meet a portion of the world's vaccine demand. In this review, an attempt is made to summarize the state-of-the-art plant-derived vaccine rostrum for infectious diseases that are in the clinical development stage and have demonstrated favorable results with reference to effectiveness and security.